Full Version
|
Search
The Irish Medicines Board - www.imb.ie
Home
About Us
Consultation
Events
Glossary
Legislation
Links
News
Publications
Recruitment
Register
Safety & Quality
Human Medicines
Veterinary
Medical Devices
Blood, Tissues, Organs
Cosmetics
Patients & Public
Home
»
Publications
»
Oral Biphosphonates and Risk of Oesophageal Cancer
Your Selection
[x]
Year
: 2010
[x] Remove All Filters
By Product
Blood, Tissues & Cells (3)
Cosmetics (6)
Drug-Device Combination Products (3)
Herbal & Homeopathic Medicines (7)
Human medicines (85)
Medical devices (19)
Veterinary (11)
By Audience / Stakeholder Group
All Stakeholders (22)
Healthcare professionals (70)
Industry (30)
Patients and consumers (5)
By Document Type
Corporate & Policy Documents (4)
Direct Healthcare Professional Communication (40)
Forms & Templates (10)
Guidance (17)
Information Leaflets (4)
Newsletters (11)
Safety Updates & Reports (40)
By Service
Clinical Investigations (1)
Export Certification (1)
Licensing – Medicines (12)
Manufacturing & Wholesale (1)
Medical Devices (3)
Product Classification (1)
Reporting Safety & Quality issues (3)
Oral Biphosphonates and Risk of Oesophageal Cancer
06 December 2010
Tags:
Human medicines
Healthcare professionals
Safety Updates & Reports
2010
Oral Biphosphonates and Risk of Oesophageal Cancer
« View Publications List
Provide Feedback
RSS Feeds
IMB Publications RSS Feed